Day: March 18, 2023

With 5.37% CAGR, Supplementary Cementitious Materials Market Size to Reach USD 17 billion by 2028

With 5.37% CAGR, Supplementary Cementitious Materials Market Size to Reach USD 17 billion by 2028

According to Exactitude Consultancy the Global Supplementary Cementitious Materials Market value is expected to reach USD 17 billion by 2029, growing at a 5.37% CAGR of Between Forecast Period 2023 and 2028. Luton, Bedfordshire, United Kingdom, March 18, 2023 (GLOBE NEWSWIRE) — Exactitude Consultancy, the market research and consulting wing of Ameliorate Digital Consultancy Private Limited has completed and published the final copy of the detailed research report on the Supplementary Cementitious Materials Market. The Global Supplementary Cementitious Materials Market is expected to grow at more than 5.37% CAGR from 2022 to 2028. It is expected to reach above USD 17 billion by 2028 from a little above USD 12 billion in 2021. The market growth is driven by the increasing demand for sustainable construction practices and the growing...

Continue reading

Positive Phase 2 Data from RAPIDe-1 Study of PHVS416 for the On-Demand Treatment of HAE Attacks Highlighted at the 2023 HAEi Regional Conference APAC

Positive Phase 2 Data from RAPIDe-1 Study of PHVS416 for the On-Demand Treatment of HAE Attacks Highlighted at the 2023 HAEi Regional Conference APAC

ZUG, Switzerland, March 18, 2023 (GLOBE NEWSWIRE) — Pharvaris (Nasdaq: PHVS), a clinical-stage company developing novel, oral bradykinin-B2-receptor antagonists to treat and prevent hereditary angioedema (HAE) attacks, today announced an oral presentation of positive data from its Phase 2 RAPIDe-1 study of PHVS416 for the on-demand treatment of attacks at the 2023 HAEi Regional Conference APAC, taking place in Bangkok, Thailand, on March 17-19, 2023. Presentation Details Title: Efficacy and Safety of Bradykinin B2 Receptor Inhibition with Oral PHVS416 in Treating Hereditary Angioedema Attacks: Results of RAPIDe-1 Phase 2 Trial Presenter: Marc A. Riedl, M.D., M.S., Professor of Medicine, Clinical Director of the US Hereditary Angioedema Association (HAEA) Angioedema Center at the University of California San Diego (UCSD), and Clinical...

Continue reading

PureGold Announces Management Departures

PureGold Announces Management Departures

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, March 17, 2023 (GLOBE NEWSWIRE) — Pure Gold Mining Inc. (NEX:PGM.H) (“PureGold” or the “Company”) announces today the departures of Mark O’Dea, President & CEO; Phil Smerchanski, VP Exploration & Technical Services; Chris Lee, Chief Geoscientist; and Adrian O’Brien, Director Marketing and Communications, effective immediately. The Company also announces the departures of Chris Haubrich, VP Business Development & CFO and Ashley Kates, VP Finance & Corporate Secretary, effective March 31, 2023. The above noted departures are taking place in consultation with the Company’s senior lender, a fund managed by Sprott Resource Lending Corp. (“Sprott”) and the court appointed Monitor in the ongoing...

Continue reading

Rubicon Organics to Report Q4 2022 Results

Rubicon Organics to Report Q4 2022 Results

VANCOUVER, British Columbia, March 17, 2023 (GLOBE NEWSWIRE) — Rubicon Organics Inc. (TSXV: ROMJ) (OTCQX: ROMJF) (“Rubicon Organics” or the “Company”), a licensed producer focused on cultivating and selling organic certified, premium cannabis products, is pleased to announce that it will be reporting its financial results for the year ended December 31, 2022 (“Q4 2022”) on Friday, March 31, 2023. The Company will be hosting a conference call to discuss Q4 2022 results on Monday, April 3, 2023. Conference call details are as follows: Time: 7:00 AM PT / 10:00 AM ET Conference ID: 24261214 Local dial-in:         +1 (416) 764 8646 Toll Free N. America: +1 (888) 396 8049 Webcast: https://viavid.webcasts.com/starthere.jsp?ei=1605437&tp_key=8f0f665564     ABOUT RUBICON ORGANICS INC. Rubicon Organics Inc. is the global...

Continue reading

Pacific Western Bank Issues End of Week Update

Pacific Western Bank Issues End of Week Update

LOS ANGELES, March 17, 2023 (GLOBE NEWSWIRE) — Pacific Western Bank, the primary subsidiary of PacWest Bancorp (NASDAQ: PACW), today issued the following statement reaffirming its financial strength. Pacific Western Bank continues to have solid liquidity, with over $10.8 billion in available cash as of March 17, 2023. Available cash exceeds total uninsured deposits. Following the announcement of the Silicon Valley Bank and Signature Bank closures, the bank experienced elevated net deposit outflows, concentrated primarily in our Venture Banking business line. Since Monday, March 13, 2023, net outflows have fallen sharply, with deposit balance fluctuations substantially stabilizing. As of March 16, 2023, insured deposits exceed 62% of total deposits, including accounts eligible for pass-through insurance. Additionally, as of March...

Continue reading

Purpose Investments Inc. Announces March 2023 Distributions for Purpose US Dividend Fund

Purpose Investments Inc. Announces March 2023 Distributions for Purpose US Dividend Fund

TORONTO, March 17, 2023 (GLOBE NEWSWIRE) — Purpose Investments Inc. (“Purpose”) is pleased to announce distributions for the month of March 2023 for Purpose US Dividend Fund. The ex-distribution date is March 23, 2023. Open-End Fund Ticker Symbol Distribution per Unit Record Date Payable Date Purpose US Dividend Fund – ETF Units PUD $0.0850 03/24/2023 03/31/2023 Purpose US Dividend Fund – ETF Non-Currency Hedged Units PUD.B $0.0980 03/24/2023 03/31/2023 About Purpose Investments Inc. Purpose Investments Inc. is an asset management company with more than $15 billion in assets under management. Purpose Investments has an unrelenting focus on client-centric innovation and offers a range of managed and quantitative investment products. Purpose Investments is led by well-known entrepreneur Som Seif and is a division of Purpose...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.